Report cover image

Chemotherapy Induced Peripheral Neuropathy Treatment Global Market Opportunities And Strategies To 2034

Publisher The Business Research Company
Published Jul 09, 2025
Length 326 Pages
SKU # BRC20178149

Description

Chemotherapy Induced Peripheral Neuropathy Treatment Global Market Opportunities And Strategies To 2034 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global chemotherapy induced peripheral neuropathy treatment market as it emerges from the COVID-19 shut down.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.
Description:

Where is the largest and fastest-growing market for chemotherapy induced peripheral neuropathy treatment? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The chemotherapy induced peripheral neuropathy treatment market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s history and forecasts market growth by geography. It places the market within the context of the wider chemotherapy induced peripheral neuropathy treatment market; and compares it with other markets.

The report covers the following chapters
  • Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by drug class, by treatment, by drug type, by distribution channel and by end-user.
  • Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
  • Growth Analysis And Strategic Analysis Framework- Analysis on PESTEL, end use industries, market growth rate, global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods, forecast growth contributors and total addressable market (TAM).
  • Regional And Country Analysis- Historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison by region and country.
  • Market Segmentation- Contains the market values (2019-2024) (2024-2029, 2034F) and analysis for each segment by drug class, by treatment, by drug type, by distribution channel and by end-user in the market. Historic (2019-2024) and forecast (2024-2029) and (2029-2034) market values and growth and market share comparison by region market.
  • Regional Market Size and Growth- Regional market size (2024), historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Other Major And Innovative Companies- Details on the company profiles of other major and innovative companies in the market.
  • Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
  • Competitive Dashboard- Briefs on competitive dashboard of major players.
  • Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
  • Recent Developments- Information on recent developments in the market covered in the report.
  • Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
  • Conclusions And Recommendations- This section includes recommendations for chemotherapy induced peripheral neuropathy treatment providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
  • Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
Markets Covered:

1) By Drug Class: Neurotransmitter-Based Therapy; Other Drug Classes

2) By Treatment: Medication; Physical Therapy; Other Treatments

3) By Drug Type: Branded; Generic

4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacies; Other Distribution Channels

5) By End User: Hospitals; Research Institutes; Specialty Clinics

Companies Mentioned: Teva Pharmaceuticals; Aurobindo Pharma Limited; Viatris Inc. (Mylan); Sun Pharmaceutical Industries Ltd.; Zydus Lifesciences Limited (formerly Cadila Healthcare Limited)

Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time-series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; chemotherapy induced peripheral neuropathy treatment indicators comparison.

Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

326 Pages
1 Executive Summary
1.1 Chemotherapy Induced Peripheral Neuropathy Treatment – Market Attractiveness And Macro Economic Landscape
2 Table Of Contents
3 List Of Tables
4 List Of Figures
5 Report Structure
6 Market Characteristics
6.1 General Market Definition
6.2 Summary
6.3 Chemotherapy Induced Peripheral Neuropathy Treatment Market Definition And Segmentations
6.4 Market Segmentation By Drug Class
6.4.1 Neurotransmitter Based Therapy
6.4.2 Other Drug Classes
6.5 Market Segmentation By Treatment
6.5.1 Medication
6.5.2 Physical Therapy
6.5.3 Other Treatments
6.6 Market Segmentation By Drug Type
6.6.1 Branded
6.6.2 Generic
6.7 Market Segmentation By Distribution Channel
6.7.1 Hospital Pharmacy
6.7.2 Retail Pharmacy
6.7.3 Online Pharmacies
6.7.4 Other Distribution Channels
6.8 Market Segmentation By End-User
6.8.1 Hospitals
6.8.2 Research Institutes
6.8.3 Specialty Clinics
7 Major Market Trends
7.1 Collaborative Research Enhances Understanding Of Chemotherapy-Induced Peripheral Neuropathy
7.2 Advances In Selective FABP5 Inhibitors For Chemotherapy-Induced Peripheral Neuropathy
7.3 Strategic Funding Advances Neuroprotective Therapies For Chemotherapy-Related Nerve Damage
8 Global Chemotherapy Induced Peripheral Neuropathy Treatment Growth Analysis And Strategic Analysis Framework
8.1 Global: PESTEL Analysis
8.1.1 Political
8.1.2 Economic
8.1.3 Social
8.1.4 Technological
8.1.5 Environmental
8.1.6 Legal
8.2 Analysis Of End User (B2B) Market
8.2.1 Hospitals
8.2.2 Research Institutes
8.2.3 Specialty Clinics
8.3 Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Growth Rate Analysis
8.4 Historic Market Growth, 2019 – 2024, Value ($ Million)
8.4.1 Market Drivers 2019 – 2024
8.4.2 Market Restraints 2019 – 2024
8.5 Forecast Market Growth, 2024 – 2029, 2034F Value ($ Million)
8.6 Forecast Growth Contributors/Factors
8.6.1 Quantitative Growth Contributors
8.6.2 Drivers
8.6.3 Restraints
8.7 Global Chemotherapy Induced Peripheral Neuropathy Treatment Total Addressable Market (TAM)
9 Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Segmentation
9.1 Global Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Class, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
9.2 Global Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
9.3 Global Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
9.4 Global Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
9.5 Global Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
9.6 Global Chemotherapy Induced Peripheral Neuropathy Treatment Market, Sub-Segmentation Of Neurotransmitter Based Therapy, By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
9.7 Global Chemotherapy Induced Peripheral Neuropathy Treatment Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
10 Chemotherapy Induced Peripheral Neuropathy Treatment Market, Regional and Country Analysis
10.1 Global Chemotherapy Induced Peripheral Neuropathy Treatment Market, By Region, Historic and Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
10.2 Global Chemotherapy Induced Peripheral Neuropathy Treatment Market, By Country, Historic and Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11 Asia-Pacific Market
11.1 Summary
11.2 Market Overview
11.2.1 Region Information
11.2.2 Market Information
11.2.3 Background Information
11.2.4 Government Initiatives
11.2.5 Regulations
11.2.6 Regulatory Bodies
11.2.7 Major Associations
11.2.8 Taxes Levied
11.2.9 Corporate Tax Structure
11.2.10 Investments
11.2.11 Major Companies
11.3 Asia-Pacific Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Class, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.4 Asia-Pacific Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.5 Asia-Pacific Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.6 Asia-Pacific Chemotherapy Induced Peripheral Neuropathy Treatment Market: Country Analysis
11.7 China Market
11.8 Summary
11.9 Market Overview
11.9.1 Country Information
11.9.2 Market Information
11.9.3 Background Information
11.9.4 Government Initiatives
11.9.5 Regulations
11.9.6 Regulatory Bodies
11.9.7 Major Associations
11.9.8 Taxes Levied
11.9.9 Corporate Tax Structure
11.9.10 Major Companies
11.10 China Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Class, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.11 China Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.12 China Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.13 India Market
11.14 India Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Class, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.15 India Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.16 India Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.17 Japan Market
11.18 Summary
11.19 Market Overview
11.19.1 Country Information
11.19.2 Market Information
11.19.3 Background Information
11.19.4 Government Initiatives
11.19.5 Regulations
11.19.6 Regulatory Bodies
11.19.7 Major Associations
11.19.8 Taxes Levied
11.19.9 Corporate Tax Structure
11.19.10 Major Companies
11.20 Japan Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Class, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.21 Japan Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.22 Japan Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.23 South Korea Market
11.24 Summary
11.25 Market Overview
11.25.1 Country Information
11.25.2 Market Information
11.25.3 Background Information
11.25.4 Government Initiatives
11.25.5 Regulations
11.25.6 Regulatory Bodies
11.25.7 Major Associations
11.25.8 Taxes Levied
11.25.9 Corporate Tax Structure
11.25.10 Investments
11.25.11 Major Companies
11.26 South Korea Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Class, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.27 South Korea Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.28 South Korea Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.29 Australia Market
11.30 Australia Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Class, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.31 Australia Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.32 Australia Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.33 Indonesia Market
11.34 Indonesia Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Class, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.35 Indonesia Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.36 Indonesia Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12 Western Europe Market
12.1 Summary
12.2 Market Overview
12.2.1 Region Information
12.2.2 Market Information
12.2.3 Background Information
12.2.4 Government Initiatives
12.2.5 Regulations
12.2.6 Regulatory Bodies
12.2.7 Major Associations
12.2.8 Taxes Levied
12.2.9 Corporate Tax Structure
12.2.10 Investments
12.2.11 Major Companies
12.3 Western Europe Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Class, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.4 Western Europe Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.5 Western Europe Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.6 UK Market
12.7 UK Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Class, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.8 UK Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.9 UK Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.10 Germany Market
12.11 Germany Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Class, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.12 Germany Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.13 Germany Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.14 France Market
12.15 France Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Class, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.16 France Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.17 France Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.18 Italy Market
12.19 Italy Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Class, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.20 Italy Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.21 Italy Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.22 Spain Market
12.23 Spain Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Class, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.24 Spain Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.25 Spain Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
13 Eastern Europe Market
13.1 Summary
13.2 Market Overview
13.2.1 Region Information
13.2.2 Market Information
13.2.3 Background Information
13.2.4 Government Initiatives
13.2.5 Regulations
13.2.6 Regulatory Bodies
13.2.7 Major Associations
13.2.8 Taxes Levied
13.2.9 Corporate Tax Structure
13.2.10 Major Companies
13.3 Eastern Europe Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Class, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
13.4 Eastern Europe Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
13.5 Eastern Europe Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
13.6 Russia Market
13.7 Russia Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Class, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
13.8 Russia Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
13.9 Russia Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
14 North America Market
14.1 Summary
14.2 Market Overview
14.2.1 Region Information
14.2.2 Market Information
14.2.3 Background Information
14.2.4 Government Initiatives
14.2.5 Regulations
14.2.6 Regulatory Bodies
14.2.7 Major Associations
14.2.8 Taxes Levied
14.2.9 Corporate Tax Structure
14.2.10 Investments
14.2.11 Major Companies
14.3 North America Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Class, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
14.4 North America Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
14.5 North America Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
14.6 North America Chemotherapy Induced Peripheral Neuropathy Treatment Market: Country Analysis
14.7 USA Market
14.8 Summary
14.9 Market Overview
14.9.1 Country Information
14.9.2 Market Information
14.9.3 Background Information
14.9.4 Government Initiatives
14.9.5 Regulations
14.9.6 Regulatory Bodies
14.9.7 Major Associations
14.9.8 Taxes Levied
14.9.9 Corporate Tax Structure
14.9.10 Investments
14.9.11 Major Companies
14.10 USA Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Class, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
14.11 USA Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
14.12 USA Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
14.13 Canada Market
14.14 Summary
14.15 Market Overview
14.15.1 Country Information
14.15.2 Market Information
14.15.3 Background Information
14.15.4 Government Initiatives
14.15.5 Regulations
14.15.6 Regulatory Bodies
14.15.7 Major Associations
14.15.8 Taxes Levied
14.15.9 Corporate Tax Structure
14.15.10 Investments
14.15.11 Major Companies
14.16 Canada Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Class, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
14.17 Canada Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
14.18 Canada Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
15 South America Market
15.1 Summary
15.2 Market Overview
15.2.1 Region Information
15.2.2 Market Information
15.2.3 Background Information
15.2.4 Government Initiatives
15.2.5 Regulations
15.2.6 Regulatory Bodies
15.2.7 Major Associations
15.2.8 Taxes Levied
15.2.9 Corporate Tax Structure
15.2.10 Major Companies
15.3 South America Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Class, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
15.4 South America Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
15.5 South America Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
15.6 Brazil Market
15.7 Brazil Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Class, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
15.8 Brazil Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
15.9 Brazil Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
16 Middle East Market
16.1 Summary
16.2 Market Overview
16.2.1 Region Information
16.2.2 Market Information
16.2.3 Background Information
16.2.4 Government Initiatives
16.2.5 Regulations
16.2.6 Regulatory Bodies
16.2.7 Major Associations
16.2.8 Taxes Levied
16.2.9 Corporate Tax Structure
16.2.10 Major Companies
16.3 Middle East Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Class, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
16.4 Middle East Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
16.5 Middle East Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
17 Africa Market
17.1 Summary
17.2 Market Overview
17.2.1 Region Information
17.2.2 Market Information
17.2.3 Background Information
17.2.4 Government Initiatives
17.2.5 Regulations
17.2.6 Regulatory Bodies
17.2.7 Major Associations
17.2.8 Taxes Levied
17.2.9 Corporate Tax Structure
17.2.10 Major Companies
17.3 Africa Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Class, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
17.4 Africa Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
17.5 Africa Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
18 Competitive Landscape And Company Profiles
18.1 Company Profiles
18.2 Teva Pharmaceutical Industries Ltd.
18.2.1 Company Overview
18.2.2 Products And Services
18.2.3 Financial Overview
18.3 Aurobindo Pharma Limited
18.3.1 Company Overview
18.3.2 Products And Services
18.3.3 Financial Overview
18.4 Viatris Inc. (Mylan)
18.4.1 Company Overview
18.4.2 Products And Services
18.4.3 Financial Overview
18.5 Sun Pharmaceutical Industries Ltd.
18.5.1 Company Overview
18.5.2 Products And Services
18.5.3 Financial Overview
18.6 Zydus Lifesciences Limited (formerly Cadila Healthcare Limited)
18.6.1 Company Overview
18.6.2 Products And Services
18.6.3 Financial Overview
19 Other Major And Innovative Companies
19.1 Lupin Limited
19.1.1 Company Overview
19.1.2 Products And Services
19.2 Sandoz Group AG
19.2.1 Company Overview
19.2.2 Products And Services
19.3 Torrent Pharmaceuticals Ltd
19.3.1 Company Overview
19.3.2 Products And Services
19.4 Alkem Laboratories Limited
19.4.1 Company Overview
19.4.2 Products And Services
19.5 Dr Reddys Laboratories Ltd.
19.5.1 Company Overview
19.5.2 Products And Services
19.6 Apotex Inc.
19.6.1 Company Overview
19.6.2 Products And Services
19.7 Eli Lilly
19.7.1 Company Overview
19.7.2 Products And Services
19.8 WEX Pharmaceuticals
19.8.1 Company Overview
19.8.2 Products And Services
19.9 Amgen Inc.
19.9.1 Company Overview
19.9.2 Products And Services
19.10 Asahi Kasei Corporation
19.10.1 Company Overview
19.10.2 Products And Services
19.11 Eisai Inc.
19.11.1 Company Overview
19.11.2 Products And Services
19.12 ESTEVE
19.12.1 Company Overview
19.12.2 Products And Services
19.13 ChromaDex Corp.
19.13.1 Company Overview
19.13.2 Products And Services
19.14 Apexian Pharmaceuticals Inc.
19.14.1 Company Overview
19.14.2 Products And Services
19.15 AnnJi Pharmaceutical Co. Ltd.
19.15.1 Company Overview
19.15.2 Products And Services
20 Competitive Benchmarking
21 Competitive Dashboard
22 Key Mergers And Acquisitions
22.1 electroCor Acquired NeuroMetrix
23 Recent Developments In The Chemotherapy Induced Peripheral Neuropathy Treatment Market
23.1 Clinical Data Highlights Potential Of Nadunolimab In Reducing Chemotherapy-Induced Peripheral Neuropathy
23.2 New Topical Agent Targeting Sodium Channels Completes Phase II Trial In CIPN
24 Opportunities And Strategies
24.1 Global Chemotherapy Induced Peripheral Neuropathy Treatment Market In 2029 – Countries Offering Most New Opportunities
24.2 Global Chemotherapy Induced Peripheral Neuropathy Treatment Market In 2029 – Segments Offering Most New Opportunities
24.3 Global Chemotherapy Induced Peripheral Neuropathy Treatment Market In 2029 – Growth Strategies
24.3.1 Market Trend Based Strategies
25 Chemotherapy Induced Peripheral Neuropathy Treatment Market, Conclusions And Recommendations
25.1 Conclusions
25.2 Recommendations
25.2.1 Product
25.2.2 Place
25.2.3 Price
25.2.4 Promotion
25.2.5 People
26 Appendix
26.1 Geographies Covered
26.2 Market Data Sources
26.3 Research Methodology
26.4 Currencies
26.5 The Business Research Company
26.6 Copyright and Disclaimer

Search Inside Report

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us